Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indivior Pharmaceuticals Inc. Common Stock (INDV) vs Stanley Black & Decker, Inc. (SWK) Price & Performance

Indivior Pharmaceuticals Inc. Common StockTrade
Stanley Black & Decker, Inc.Trade

Price performance (Past 24H)

Key statistics

Indivior Pharmaceuticals Inc. Common Stock vs Stanley Black & Decker, Inc. — how do they compare? Indivior Pharmaceuticals Inc. Common Stock trades at $34.01 (market cap $4.18B), while Stanley Black & Decker, Inc. trades at $90.33 (market cap $13.70B). The key difference: Stanley Black & Decker, Inc. is far larger — about 3.3× Indivior Pharmaceuticals Inc. Common Stock's market cap, and Stanley Black & Decker, Inc. pays a 3.7% dividend while Indivior Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Indivior Pharmaceuticals Inc. Common Stock for 0 Days and Stanley Black & Decker, Inc. for 62 Days on average.

INDVSWK
Market Cap
$4.18B$13.70B
Volume
1,819,7461,098,669
Sector
HealthIndustrials
52-Week High
$41.83$104.00
52-Week Low
$24.09$62.12
Typical Hold Time
0 Days62 Days
Enterprise Value
$4.47B$17.86B
Dividend Yield
—3.7%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Indivior Pharmaceuticals Inc. Common Stock

No Aura AI signal available yet.

Stanley Black & Decker, Inc.

Stanley Black & Decker (SWK) trades at $90.29, up 1.85% today, with a bearish technical signal from moving averages despite recent earnings beats. The company shows improving profitability with a net income margin of 4.07% in 2025, and revenue is projected to grow to $15.2B in 2026. Recent news highlights product launches like the dustbuster mini and management's focus on margin gains and brand strength.

The outlook is cautiously optimistic with a consensus price target of $93.00, offering modest upside. Key risks include competitive pressures and execution challenges, but strong institutional buying and a dividend history support long-term value. Investors should weigh improving fundamentals against near-term technical weakness.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

INDV
100% Buy0% Sell
Avg holding period · 0 Days
SWK

No sentiment data available yet.

About Indivior Pharmaceuticals Inc. Common Stock

Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.

Read more on INDV →

About Stanley Black & Decker, Inc.

Stanley Black & Decker Inc is a manufacturer of hand and power tools. The company operates three business segments: tools and storage, security, and industrial. Tools and storage, the largest segment by revenue, sells hand tools and power tools to professional end-users, distributors, retail consumers, and industrial customers. Security installs electronic security systems and provides electronic security services including alarm monitoring and video surveillance. Industrial sells engineered fastening products such as stud-welding systems, blind inserts and tools, and engineered plastic and mechanical fasteners. The largest end market is the United States of America.

Read more on SWK →